Cancer Research Audrey Hepburn  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 936-939, May 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ray, P. K.
Right arrow Articles by Simmons, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ray, P. K.
Right arrow Articles by Simmons, R. L.

Differential Release of Sialic Acid from Normal and Malignant Cells by Vibrio cholerae Neuraminidase or Influenza Virus Neuraminidase1

Prasanta K. Ray and Richard L. Simmons2

Department of Surgery, University of Minnesota, Minneapolis, Minnesota 55455

A comparison was made between the amounts of sialic acid released from viable cell suspensions of normal and malignant cells by Vibrio cholerae neuraminidase (VCN) and by influenza virus neuraminidase. More sialic acid can be removed by enzyme digestion from various tumors than from normal lymphoid cells. More sialic acid can be removed from the surface of both normal and tumor cells by VCN than by influenza virus neuraminidase. VCN lyses the 2–3, 2–6, and 2–8 glycosidic linkages between sialic acid and the mucopolysaccharides of the cell surface, and influenza virus neuraminidase lyses only the 2–3 and 2–8 linkages. Therefore, it appears that most cell-surface sialic acid residues are bound by the 2–6 linkage on both normal and malignant cells. The relative increase in cell-surface sialic acid residues may be important to tumor immunotherapy, since the removal of cell-surface sialic acid residues with VCN increases the immunogenicity of tumor cells.

1 Supported in part by Grant RO1 CA11605 from the USPHS and Grant IC-9 from the American Cancer Society.

2 To whom reprint requests should be sent, at Box 185, Mayo Memorial Building, University of Minnesota, Minneapolis, Minn. 55455.

Received 9/29/72. Accepted 1/24/73.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. KARPATKIN and E. PEARLSTEIN
Role of Platelets in Tumor Cell Metastases
Ann Intern Med, November 1, 1981; 95(5): 636 - 641.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.